CLDN1 and breast carcinoma: In breast cancer, the expression of claudin-1 was found to be downregulated in estrogen receptor (ER)-positive luminal A and luminal B breast cancer, while increased expression was observed in ER-negative basal-like breast cancer subtype [37].